EMD-41727

Single-particle
2.75 Å
EMD-41727
3D View Gallery
Deposition: 25/08/2023
Map released: 07/02/2024
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-41727

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8tyo summary report (pdf.gz) Map-8tyo FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2

EMD-41727

Single-particle
2.75 Å
EMD-41727
3D View Gallery
Deposition: 25/08/2023
Map released: 07/02/2024
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 Spike trimer antigen from variant B.1.351
Fitted models: 8tyo

Deposition Authors: Bruch EM , Rak A
Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2.
Bruch EM , Zhu S, Szymkowicz L, Blake T, Kiss T, James DA, Rak A , Narayan K, Balmer MT, Chicz RM
(2024) Sci Rep , 14 , 2038 - 2038
PUBMED: 38263191
DOI: doi:10.1038/s41598-024-52499-1
ISSN: 2045-2322
Grant Support: